Delivery Order SPE2DB20D2104-SPE2DB23FV51R

Award Date 9/25/23
Potential Completion Date 9/26/23
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,559,406,389 units of Naloxone HCl 4 mg Nasal Spray to the Defense Logistics Agency (DLA). The award, valued at $3,854.16, was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 19, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,357.92, is a delivery order to provide 4,565,123,305 units of the drug Naloxone HCL 4 mg Nasal Spray. The contract has an ultimate completion date of July 12, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. is a Delivery Order (SPE2DB23FV04P) valued at $1,494.12 for the procurement of 4,561,936,958 units of Naloxone HCL 4 mg Nasal Spray. The contract has an ultimate completion date of August 25, 2023 and was awarded on August 24, 2023. AmerisourceBergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $7,431.79 for the supply of 4,559,121,146 units of 4 mg naloxone hydrochloride nasal spray. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,367,200 units of Naloxone HCL 4 mg Nasal Spray. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,950.71 and an ultimate completion date of August 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of 4,566,749,486 units of Naloxone HCL 4 mg Nasal Spray. The firm-fixed-price delivery order has a ceiling value of $2,086.45 and a completion date of December 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor with no set-aside designation indicated. The contract is an Indefinite Delivery Contract (IDC) valued at $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,194.32 Firm Fixed Price delivery order covers the supply of 4,561,769,383 units of Naloxone HCl 4 mg Nasal Spray, with an ultimate completion date of August 11, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,557,932,236 units of Naloxone HCL 4 mg Nasal Spray. The $3,078.00 firm fixed-price delivery order has a completion date of July 29, 2022 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4,564,960,168 units of Naloxone HCl 4 mg nasal spray. The firm-fixed-price contract, valued at $3,088.40, has a completion date of June 21, 2024. AmerisourceBergen, a major pharmaceutical distribution company, has extensive experience fulfilling government contracts for a wide range of medical products, including prescription medications,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,081.74 firm-fixed-price delivery order is for the supply of 4,559,542 units of 4 mg naloxone hydrochloride nasal spray. The contract has an ultimate completion date of January 10, 2023 and is not associated with any set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FV51R
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,271.05, is for the delivery of 4,562,300 units of Naloxone HCL 4 mg nasal spray. This is a Firm Fixed Price Delivery Order contract that runs through September 26, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.

Generated 5/12/25, 10:11 AM